Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

MLA

Andrews DW, et al. “Whole Brain Radiation Therapy with or without Stereotactic Radiosurgery Boost for Patients with One to Three Brain Metastases: Phase III Results of the RTOG 9508 Randomised Trial.” Lancet, vol. 363, no. 9422, May 2004, pp. 1665–72. EBSCOhost, https://doi.org/10.1016/s0140-6736(04)16250-8.

APA

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary J, Souhami L, Rotman M, Mehta MP, & Curran WJ Jr. (2004). Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet, 363(9422), 1665–1672. https://doi.org/10.1016/s0140-6736(04)16250-8

Chicago

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, et al. 2004. “Whole Brain Radiation Therapy with or without Stereotactic Radiosurgery Boost for Patients with One to Three Brain Metastases: Phase III Results of the RTOG 9508 Randomised Trial.” Lancet 363 (9422): 1665–72. doi:10.1016/s0140-6736(04)16250-8.